SAS Output

23-FEB-2019 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 148 32 14 7 3 1 1 07/25/2016 212 88
        2 Cabozantinib   29 12 4 1 1 0      
        3 Crizotinib   28 10 0 0 0 0      
        4 Savolitinib   30 11 4 1 0 0      
            119 47 15 5 2 1      
 
  S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 Y 1 TICE BCG 969 80 55 30 17 6 1 02/24/2017 182 70
        2 Tokyo-172 BCG   79 55 31 16 5 0      
        3 Prime + Tokyo-172 BCG   78 55 31 16 5 2      
            237 165 92 49 16 3      
 
  S1605-Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 Y 1 Atezolizumab 162 122 87 55 23 6 1 03/13/2017 196 92
            122 87 55 23 6 1      
 
  S1802-Pros, Stg IV, SST +/- Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 35 35 35 17 6 1 09/24/2018 184 80
            35 35 35 17 6 1      
 
    2 Y 1 Standard Systemic Therapy Only 1273 5 5 5 2 1 0 09/24/2018    
        2 SST + Surgery/RT   6 6 6 2 1 0      
            11 11 11 4 2 0      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   4 2 1 0 0 0 11/23/2016 56 34
            4 2 1 0 0 0      
 
  EA8143-RCC, HR, Surg +/- Nivolumab (PROSPER) 0 E Total Registrations   34 27 15 10 3 2 09/29/2017 323 146
            34 27 15 10 3 2      
 
    1 E Total Registrations   26 20 11 8 2 2 09/29/2017    
            26 20 11 8 2 2      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   2 1 1 0 0 0 08/24/2017 224 108
            2 1 1 0 0 0      
 
    2 E Total Registrations   2 1 1 1 0 0 08/24/2017    
            2 1 1 1 0 0      
 
No A031501-Bladder, MIBC/Loc Adv, Adjv Pembro vs Obs 0 E Total Registrations   28 28 19 15 4 0 05/03/2018 238 123
            28 28 19 15 4 0      
 
    1 E Total Registrations   25 25 18 15 4 1 05/03/2018    
            25 25 18 15 4 1      
 
  A031701-Bladder, ddGC for MIBC with DDR Tumor Alt 1 E Total Registrations   1 1 1 1 0 0 12/17/2018 17 3
            1 1 1 1 0 0      
 
  EA8153-Pros, ADT + Abira +/- Cabazitaxel (CHAARTED2) 1 E Total Registrations   4 4 2 2 0 0 08/08/2018 95 24
            4 4 2 2 0 0      
 
  R0924-Pros, NADT+WPRT vs. NADT+P&SV RT 1 E Total Registrations   92 25 5 2 1 1 11/25/2013 263 122
            92 25 5 2 1 1